Enlivex Statistics
Total Valuation
Enlivex has a market cap or net worth of $24.34 million. The enterprise value is $8.26 million.
Important Dates
The next estimated earnings date is Wednesday, April 29, 2026, after market close.
| Earnings Date | Apr 29, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Enlivex has 23.86 million shares outstanding. The number of shares has increased by 20.50% in one year.
| Current Share Class | 237.38M |
| Shares Outstanding | 23.86M |
| Shares Change (YoY) | +20.50% |
| Shares Change (QoQ) | +0.80% |
| Owned by Insiders (%) | 3.16% |
| Owned by Institutions (%) | 0.71% |
| Float | 55.07M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 1.50 |
| P/TBV Ratio | 1.47 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 6.43, with a Debt / Equity ratio of 0.04.
| Current Ratio | 6.43 |
| Quick Ratio | 6.26 |
| Debt / Equity | 0.04 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -57.64% and return on invested capital (ROIC) is -40.13%.
| Return on Equity (ROE) | -57.64% |
| Return on Assets (ROA) | -36.02% |
| Return on Invested Capital (ROIC) | -40.13% |
| Return on Capital Employed (ROCE) | -81.64% |
| Weighted Average Cost of Capital (WACC) | 12.93% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$178,887 |
| Employee Count | 71 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -8.93% in the last 52 weeks. The beta is 1.64, so Enlivex's price volatility has been higher than the market average.
| Beta (5Y) | 1.64 |
| 52-Week Price Change | -8.93% |
| 50-Day Moving Average | 1.08 |
| 200-Day Moving Average | 1.08 |
| Relative Strength Index (RSI) | 41.77 |
| Average Volume (20 Days) | 218,174 |
Short Selling Information
The latest short interest is 563,947, so 0.24% of the outstanding shares have been sold short.
| Short Interest | 563,947 |
| Short Previous Month | 521,667 |
| Short % of Shares Out | 0.24% |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 1.66 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -14.62M |
| Pretax Income | -12.70M |
| Net Income | -12.70M |
| EBITDA | -14.33M |
| EBIT | -14.62M |
| Earnings Per Share (EPS) | -$0.54 |
Full Income Statement Balance Sheet
The company has $18.20 million in cash and $701,000 in debt, with a net cash position of $17.50 million or $0.73 per share.
| Cash & Cash Equivalents | 18.20M |
| Total Debt | 701,000 |
| Net Cash | 17.50M |
| Net Cash Per Share | $0.73 |
| Equity (Book Value) | 17.48M |
| Book Value Per Share | 0.72 |
| Working Capital | 16.47M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -$11.87 million and capital expenditures -$95,000, giving a free cash flow of -$11.97 million.
| Operating Cash Flow | -11.87M |
| Capital Expenditures | -95,000 |
| Depreciation & Amortization | 292,000 |
| Net Borrowing | n/a |
| Free Cash Flow | -11.97M |
| FCF Per Share | -$0.50 |
Full Cash Flow Statement Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
Enlivex does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -20.50% |
| Shareholder Yield | -20.50% |
| Earnings Yield | -49.29% |
| FCF Yield | -46.45% |
Analyst Forecast
The average price target for Enlivex is $13.00, which is 1,174.51% higher than the current price. The consensus rating is "Buy".
| Price Target | $13.00 |
| Price Target Difference | 1,174.51% |
| Analyst Consensus | Buy |
| Analyst Count | 2 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Forecasts Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |